Menu
About Us
Company Overview
Corporate Culture
Manufacturing Base
MAH
Drug Development to Commercialization
Milestones
Code of Business Ethics
Services
Services
Providing reliable CDMO solutions with excellent quality and professional services
ADC Platform
Overview
ADC R&D Service Platform
Conjugation Process
Development
and Optimization
Drug Product
Formulation and
Lyophilization Process
Analysis Services
Antibody Manufacturing
ADC Drug Substance
Manufacturing
Lyophilized Drug
Product Manufacture
Protein/Antibody Platform
Overview
Cell Culture
Process Development
Purification Process
Development
Drug Product
Formulation and
Lophilization Process
Analysis Services
GMP Manufacturing
Overview
Drug Substance
Manufacturing
Drug Product
Manufacturing
Process Characterization
/Process Validation
Technology Transfer
Overview
Technology Transfer
Quality
Overview
Quality Control
Quality Assurance
Regulatory Affairs
Overview
Service and Advantages
Investor Relations
Company Profile
Corporate Governance
Announcements and Circulars
The Listed Files
Financial Reports and ESG Reports
Company Promotion Materials
Investor Relations Query
Investor Relations Journal
News & Events
News
Events
Media Attention
Partner News
Resources
Technical Articles
Download Center
Join Us
Members of TOT
Join in TOT
Contact Us
EN
繁體
简体
EN
繁體
简体
Home
<
News&Events
<
News
第六届中国生物医药创新合作大会
Date Time:2022-08-04
日期:2022年8月4日-5日
地址:苏州金鸡湖凯宾斯基大酒店
展位号:E01
8月4日-5日,第六届中国生物医药创新合作大会暨2022中国生物医药产业价值榜颁奖盛典于苏州金鸡湖凯宾斯基大酒店圆满召开。 本次大会,东曜药业携手博瑞医药联合布展,来自东曜药业的段清博士、黄鹏博士受邀参会。在8月4日晚举行的颁奖典礼上,“2022中国生物医药产业价值榜”盛大发布,东曜药业荣获“最具成长性CXO企业”奖项。
上一篇:
基于QbD的技术转移实施及案例分享
下一篇:
ADC药物研发的挑战和策略
微信
领英
复制链接
The module is under construction